GGrantIndex
Sort

85,873 grants matching alzheimers

Alzheimer's Disease Patient Registry (ADPR)

$2,449,113
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2009 · AG

Mitochondrial Energetics, Circuits and Cognitive Decline in the Aging Human Brain

$2,449,033
Martin Picard · Columbia University Health Sciences · RF1 · FY2022 · AG

Chronic Traumatic Encephalopathy: Detection, Diagnosis, Course, and Risk Factors

$2,448,976
Robert A Stern · Boston University Medical Campus · U01 · FY2018 · NS

Velocity-Selective Arterial Spin Labeling based Perfusion Mapping for Alzheimer's disease

$2,448,470
Qin Qin · Johns Hopkins University · RF1 · FY2023 · AG

The University of Kentucky MarkVCID Biomarker Validation Cohort: Development of a Toolbox to Advance VCID Interventional Studies

$2,448,000
Gregory A Jicha · University Of Kentucky · UF1 · FY2021 · NS

Novel Approaches to Understand the Pathogenesis and Treat Alzheimer's Disease

$2,447,228
Thomas M Wisniewski · New York University School Of Medicine · P01 · FY2021 · AG

Role of central and peripheral immune crosstalk in FTD-Grn neurodegeneration

$2,446,942
Marialourdes G Tansey · University Of Florida · RF1 · FY2022 · NS

Causes and Consequences of Healthcare Efficiency

$2,445,924
Jonathan S Skinner · Dartmouth College · P01 · FY2019 · AG

Synaptic Circuitry of Auditory Neurons

$2,445,775
Catherine Weisz · National Institute On Deafness And Other Communication Disorders · ZIA · FY2025 · DC

Cell and Molecular Pathobiology of Alzheimer's Disease

$2,443,714
Ralph A. Nixon · Nathan S. Kline Institute For Psych Res · P01 · FY2017 · AG

P-CARRS-BRAIN: Multi-domain (genetic, socio-behavioral, vascular) risk factors and prediction of Alzheimer’s Disease continuum in South Asians in India

$2,442,538
Kabayam M Venkat Narayan · Emory University · R01 · FY2025 · AG

BET-BD1 Selective Neuroimaging probes for Alzheimer's disease research

$2,442,345
Changning Wang · Massachusetts General Hospital · RF1 · FY2023 · AG

Alzheimer's Disease Research Center

$2,442,191
Washington University · P50 · FY2005 · AG

Protein Trafficking In The Endosomal-Lysosomal System

$2,442,075
Juan Bonifacino · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2017 · HD

Validation of Biomarkers of Small Vessel Injury in VCID

$2,441,705
Gary Allen Rosenberg · University Of New Mexico Health Scis Ctr · UF1 · FY2021 · NS

Development and Validation of a Genetically Encoded Method to Trace and Manipulate Neuronal Circuits in Zebrafish

$2,440,479
David Aaron Prober · California Institute Of Technology · RF1 · FY2022 · MH

Alzheimer's Disease Research Center - Overall

$2,440,109
Scott A Small · Columbia University Health Sciences · P50 · FY2015 · AG

Health, Aging and Dementia in South Africa: A Longitudinal Study (HAALSI)

$2,439,585
Lisa F Berkman · Harvard University D/B/A Harvard School Of Public Health · P01 · FY2025 · AG

Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease

$2,439,205
Berislav V Zlokovic · University Of Southern California · P01 · FY2017 · AG

The role of ATP13A5 ATPase in determining blood-brain pericyte functions

$2,438,887
Zhen Zhao · University Of Southern California · RF1 · FY2023 · NS

Exploring Cognitive Aging Using Reference Ability Neural Networks

$2,438,587
Yaakov Stern · Columbia University Health Sciences · R01 · FY2021 · AG

The adaptive-innate immune interactome across multiple tissues in Alzheimer's disease

$2,438,178
Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AG

Cell-Type Specific Vulnerability to Tauopathy and Its Prevention in Multiple Models

$2,438,130
Einar M Sigurdsson · New York University School Of Medicine · RF1 · FY2021 · NS

Mitochondrial and Metabolic Dysfunction in Age-related Neurodegeneration

$2,437,958
Gary E Gibson · Winifred Masterson Burke Med Res Inst · P01 · FY2016 · AG

Hyaluronan in brain extracellular space as a regulator of glymphatic clearance of Abeta

$2,437,500
Yu Yamaguchi · Sanford Burnham Prebys Medical Discovery Institute · RF1 · FY2017 · AG